methyldopa has been researched along with ferrous sulfate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greene, RJ; Hall, AD; Hider, RC | 1 |
| Campbell, NR; Campbell, RR; Hasinoff, BB | 1 |
| Campbell, N; Paddock, V; Sundaram, R | 1 |
1 trial(s) available for methyldopa and ferrous sulfate
| Article | Year |
|---|---|
Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Drug Interactions; Female; Ferrous Compounds; Humans; Hypertension; Intestinal Absorption; Male; Methyldopa; Random Allocation | 1988 |
2 other study(ies) available for methyldopa and ferrous sulfate
| Article | Year |
|---|---|
The interaction of orally administered iron with levodopa and methyldopa therapy.
Topics: Administration, Oral; Drug Interactions; Ferric Compounds; Ferrous Compounds; Humans; Hydrogen-Ion Concentration; Levodopa; Methyldopa; Oxidation-Reduction; Spectrophotometry, Ultraviolet | 1990 |
Ferrous sulfate reduces methyldopa absorption: methyldopa: iron complex formation as a likely mechanism.
Topics: Animals; Chromatography, High Pressure Liquid; Duodenum; Ferric Compounds; Ferrous Compounds; Intestinal Absorption; Male; Methyldopa; Oxidation-Reduction; Oxygen Consumption; Rats; Rats, Inbred Strains; Spectrophotometry | 1990 |